由辉瑞一手孵化,现在拟被默克收购

生物制药小编
28 Apr

不出意外,SpringWorks Therapeutics要被德国默克收购了。近日,两家公司已就收购价上达成一致,德国默克将以每股47美元收购SpringWorks,收购总价约为35亿美元,如果后续收购工作顺利,该交易将在下周内完成。由辉瑞一手孵化SpringWorks成立于2017年,是一家专注于癌症和罕见病药物开发的Biotech公司,2019年在纳斯达克证券交易所上市。SpringWorks...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10